Literature DB >> 15891429

Idiopathic pulmonary arterial hypertension in children.

Erika Berman Rosenzweig1, Robyn J Barst.   

Abstract

PURPOSE OF REVIEW: Until recently, the diagnosis of idiopathic pulmonary arterial hypertension was virtually a death sentence, particularly for children. Although there is no cure for idiopathic pulmonary arterial hypertension, recent medical advances have dramatically changed the course of this disease in children. A review of some of the latest medical advances will provide the reader with a better understanding of the most current treatment options for children with idiopathic pulmonary arterial hypertension. RECENT
FINDINGS: The literature reviewed demonstrate sustained clinical and hemodynamic improvement in children with various types of pulmonary arterial hypertension as well as increased survival in patients with idiopathic pulmonary arterial hypertension using current treatment strategies.
SUMMARY: This article will provide an overview of how the current diagnostic and treatment strategies of idiopathic pulmonary arterial hypertension in children have advanced over the last several years and how this impacts on clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891429     DOI: 10.1097/01.mop.0000163356.51027.c1

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  11 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.

Authors:  Leah Leibovitch; Ilan Matok; Gideon Paret
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

4.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

5.  Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy.

Authors:  A Y Wen; I K Weiss; R B Kelly
Journal:  Infection       Date:  2013-01-18       Impact factor: 3.553

6.  Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension.

Authors:  Anna Bernus; Brandie D Wagner; Frank Accurso; Aimee Doran; Heidi Kaess; D Dunbar Ivy
Journal:  Chest       Date:  2008-10-10       Impact factor: 9.410

7.  Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.

Authors:  D Dunbar Ivy; Erika Berman Rosenzweig; Jean-Christophe Lemarié; Monika Brand; Daniel Rosenberg; Robyn J Barst
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

Review 8.  Pediatric pulmonary arterial hypertension.

Authors:  Dan-Chen Wu; Hong-Da Zhang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 9.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 10.  Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate.

Authors:  Kelley L Colvin; Melanie J Dufva; Ryan P Delaney; D Dunbar Ivy; Kurt R Stenmark; Michael E Yeager
Journal:  Front Pediatr       Date:  2014-02-03       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.